GLUTAMINE (GLN) MARKET REPORT OVERVIEW
- Request a Free sample to learn more about this report
The global glutamine (GLN) market size was USD 149.7 million in 2022 and is projected to touch USD 200.51 million by 2031, exhibiting a CAGR of 3.3% during the forecast period. In the market study, our analysts have considered glutamine (GLN) players such as Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua and Fufeng.
L-glutamine and D-glutamine are the two different forms of glutamine. The D enantiomer of glutamine, which is prevalent in the human body and plays a role in metabolic processes, is known as D-glutamine. It serves as an energy source for some cells and carries nitrogen throughout the body. L-glutamine, on the other hand, promotes immune cell activity in the gut, preventing inflammation and infection, and soothes intestinal tissues. It also supports intestinal health, alleviates IBS symptoms, and enhances immunity.
The chemical compound is available in two varieties: nutraceutical grade and pharmaceutical grade. Nutraceutical and pharmaceutical are two major applications of the substance. Growing pharmaceutical demand due to the rise in various chronic and lifestyle-related health problems along with a booming elderly population will drive the market growth. Meanwhile, nutraceutical demand is rising due to increased uptake of sports and physical fitness activities. These trends will positively influence the market outlook in the coming years.
COVID-19 Impact: Market Growth Impeded by a Stoppage of Operations
The global COVID-19 pandemic has been unprecedented and staggering, with glutamine experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The spike in CAGR is attributable to the glutamine (GLN) market growth and demand returning to pre-pandemic levels once the pandemic is over.
The major players in the market were unable to satisfy customer demand due to issues in production and supply chains. The main cause of the glutamine (GLN) shortage was the reduced manufacturing owing to the suspension of export-import activity. The supply chains were broken, which caused issues for firms, including limited manpower, a shortage of raw materials, and sluggish logistics. Additionally, the supply was stagnant for a major duration of 2020, which decreased the demand for foods high in glutamine, such as meat, cattle, poultry, and dairy. All these factors affected the product demand and glutamine (GLN) market growth during the pandemic.
LATEST TRENDS
"Advancing Drug Discovery Landscape to Bring New Opportunities "
Growth in the pharmaceutical sector as a result of dietary changes and an increase in illnesses including diabetes, cancer, Alzheimer’s, and obesity are leading to an increased demand for glutamine in the pharmaceutical sector. Due to the increasing burden of various serious and life-threatening diseases, the pharmaceutical sector is experiencing rapid growth and drug discovery and development are gaining momentum. In the pharmaceutical industry, glutamine is utilized to create drugs that treat conditions including cancer, cystinuria, sickle cell anemia, anxiety, insomnia, and AIDS as well as digestive issues like stomach ulcers. The uses of glutamine, which are continuously expanding, will fuel its demand in the pharmaceutical sector.
The personal care and cosmetics industries have also seen a boom in glutamine demand as a result of rising disposable income, expanding grooming trends, and rising consumer desire for personal care goods.
Making baby goods, cleaning products, bath products, and various skin conditioning products all benefit from glutamine's role in cell regeneration. Additionally, glutamine contains antioxidant characteristics that enable it to combat dangerous poisons and free radicals. The need for glutamine has grown worldwide as a result of its many advantages, which will create lucrative opportunities for the market in the coming years.
GLUTAMINE (GLN) MARKET SEGMENTATION
- Request a Free sample to learn more about this report
- By Type Analysis
By type, market is segmented into pharmaceutical grade, nutraceutical grade, and others. Pharmaceutical grade segment will dominate the market in the coming years.
- By Application Analysis
Based on applications, the market is classified into nutraceutical use, pharmaceutical use, and others. The nutraceutical use segment will lead the global share through 2028.
DRIVING FACTORS
"Body Building and Health Benefits to Increase the Product Demand"
The millennial bodybuilding craze and the rise in demand for expensive supplements to provide better and quicker results are the main drivers of the worldwide glutamine (GLN) market share. Glutamine can work wonders for poor muscle density, aid in muscle recovery, repair damaged muscles, and aid in the growth of new, robust muscles. The fact that glutamine strengthens one's immune system is another important aspect driving the global glutamine (GLN) market growth.
"Rising Demand in Pharmaceuticals and Nutraceuticals to Augment Market Growth"
The global glutamine (GLN) market share will be augmented by the rising demand from the pharmaceutical sector, rising need for supplements, spike in uses of glutamine in treating various disorders, and growth in demand from emerging countries. Pharmaceuticals and nutraceuticals are key areas of application for the product and will generate robust demand over the next few years. Expanding uses in these sectors will strengthen the market outlook.
RESTRAINING FACTORS
"Government Regulations and Lack of Customer Awareness Could Affect Product Demand"
The development of the worldwide glutamine market is hampered by strict government regulations on its usage, worries about protein supplements that are packed, and a lack of customer confidence in the use of different supplements. The lack of knowledge regarding glutamine continues to be a major obstacle for the glutamine industry internationally.
GLUTAMINE (GLN) MARKET REGIONAL INSIGHTS
- Request a Free sample to learn more about this report
Due to rising obesity rates, increased awareness of healthy lifestyles, an increase in the amount of fitness applications, and improvements in wearable technology, North America now holds the majority share in the glutamine (GLN) market. Growing fitness trends and the availability of more exercise facilities in the US are promoting product growth.
Consumer demand has recently shifted away from industrial food items and toward healthy alternatives. The U.S.'s reduced nutritional consumption and growing health problems have increased demand for dietary supplements, which is fueling the market's expansion. The region's product demand is anticipated to be driven by government initiatives to increase athletes' participation in competition at the national and international levels.
Due to the region's growing need for supplements and shifting demographics, Asia Pacific offers plenty of potential prospects in the glutamine market. The expanding middle class in China and the increase in millennials are driving increased demand for supplements. The expanding Chinese sports nutrition market is expected to benefit a single amino acid product like glutamine. The biggest sports nutrition markets in the area are in Japan, China, and India, and it is anticipated that these markets would increase demand for glutamine.
KEY INDUSTRY PLAYERS
"Leading Players adopt Acquisition Strategies to Stay Competitive "
Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market.
List of Market Players Profiled
Ajinomoto (Japan)
Kyowa Hakko Kirin (Japan)
Daesang (South Korea)
Meihua (China)
Fufeng (China)
REPORT COVERAGE
The examination of many aspects that contribute to the market's growth has been enclosed within the analysis report. Market trends, restrictions, and drivers that have a positive or negative influence on the market make up this category. This section conjointly discusses the numerous sectors and applications that will have a control on the market within the future. the info is predicated on current trends further as historical milestones. This section conjointly includes a breakdown of production volume on the worldwide market and for every class. the quantity of output by region is mentioned during this section. The analysis includes a rating analysis for every kind, manufacturer, area, and worldwide value.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 149.7 Million in 2022 |
Market Size Value By |
US$ 200.51 Million by 2028 |
Growth Rate |
CAGR of 3.3% from 2022 to 2028 |
Forecast Period |
2024 - 2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the glutamine (GLN) market expected to touch by 2031
The glutamine (GLN) market is projected to touch USD 200.51 million by 2031.
-
What CAGR is the glutamine (GLN) market expected to exhibit by 2031
CAGR of 3.3% is the glutamine (GLN) market expected to exhibit by 2031.
-
Which are the driving factors of the glutamine (GLN) market
Increasing demand in pharmaceuticals and nutraceuticals will boost the glutamine (GLN) market growth.
-
Which are the top companies operating in the glutamine (GLN) market
Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua, and Fufeng are some of the major companies in the glutamine (GLN) market.